Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

77.61 +0.03 (+0.03%)
Streaming Delayed Price Updated: 1:12 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Thera

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Nasdaq Dips 250 Points; Crude Oil Moves Higher
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 250 points on Friday. 
Via Benzinga
Here's How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years
Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a... 
Via Benzinga
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
  GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
GCT Stock Alert: What Is Going on With GigaCloud Technology Today?
GigaCloud Technology (GCT) stock is continuing to rally on Friday after the Hong Kong-based fintech company launched its IPO yesterday. 
Via InvestorPlace
Why Is Volcon (VLCN) Stock Up 56% Today?
Volcon (VLCN) stock is rocketing higher on Friday after the EV company revealed massive pre-production orders for its Stag. 
Via InvestorPlace
Why Is Axsome Therapeutics (AXSM) Stock Up 30% Today?
Biopharmaceutical company AXSM stock is getting a huge lift from news the FDA has approved its depression treatment. 
Via InvestorPlace
Axsome's Depression Candidate Scores FDA Nod, Stock Surges To 52-High
Via Benzinga
Axsome Therapeutics: Q2 Earnings Insights
  Axsome Therapeutics (NASDAQ:AXSM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Dow Falls Over 200 Points; Deere Earnings Miss Estimates
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Axsome Shares Shoot Higher As FDA Approves Major Depressive Disorder Candidate
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ: AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of... 
Via Benzinga
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
Today's depression drugs don't fit many patients' needs. Biotech companies may change that. 
Via Investor's Business Daily
What 4 Analyst Ratings Have To Say About Axsome Therapeutics
  Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Analyst Ratings for Axsome Therapeutics
Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter: 
Via Benzinga
Axsome Therapeutics Just Took Its Key Moving Averages — Here's Why
The stock surged by double digits in early trading. 
Via Investor's Business Daily
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
7 Small-Cap Growth Stocks With 1,000% Upside Potential
Here're 7 small-cap growth stocks with 1,000% upside potential. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments. 
Via InvestorPlace
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the... 
Via Benzinga
7 Biotech Stocks to Buy for Q3
These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential. 
Via InvestorPlace
Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
Via Investor's Business Daily
Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say. 
Via Investor's Business Daily
What SVB Says On Axsome's Strategy Review On Sunosi For Sleeping Disorder
Axsome Therapeutics Inc (NASDAQ: AXSM) held an investor event to review its strategy with Sunosi, which is indicated for excessive daytime sleepiness (EDS) in narcolepsy and obstructive sleep apnea... 
Via Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
EV Stocks TSLA, NIO, RIVN See Price Targets Slashed
Electric vehicle (EV) stocks are in the news today after Mizuho analyst Vijay Rakesh weighed in on several companies in the space. 
Via InvestorPlace
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
Axsome Therapeutics Inc (NASDAQ: AXSM) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment... 
Via Benzinga
Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs. 
Via InvestorPlace
U.S. Markets Open Lower; Durable Goods Orders Rise 0.7%
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping over 100 points on Monday. 
Via Benzinga
Why Axsome Therapeutics Stock Is Soaring Today
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.